Manju Beier, Pharm D, is a distinguished Senior Partner and Founder at Geriatric Consultant Resources LLC (GCR LLC), where she has been instrumental in advancing the field of geriatric pharmacotherapy since the company's inception in 1995. With a deep-seated expertise in pharmacogenomics, Dr. Beier specializes...
Manju Beier, Pharm D, is a distinguished Senior Partner and Founder at Geriatric Consultant Resources LLC (GCR LLC), where she has been instrumental in advancing the field of geriatric pharmacotherapy since the company's inception in 1995. With a deep-seated expertise in pharmacogenomics, Dr. Beier specializes in the application of pharmacogenomic principles to clinical therapeutics, particularly in the realms of psychiatry and pain management. Her innovative approach integrates clinical outcomes into Electronic Health Records (EHRs), facilitating the evaluation of feasibility and implementation of pharmacogenomic testing in diverse healthcare settings.
At GCR LLC, Dr. Beier leads key projects aimed at developing clinical trials that identify biomarkers associated with neuropsychiatric disorders and pain modulation pathways. Her research focuses on pharmacokinetic and pharmacodynamic biomarkers, as well as single nucleotide polymorphisms (SNPs) that play a critical role in tailoring personalized treatment plans for geriatric patients. This work not only enhances therapeutic efficacy but also mitigates the risk of adverse drug reactions, a significant concern in the aging population.
Dr. Beier is recognized as an excellent presenter in geriatric pharmacotherapy, frequently sharing her insights at professional organizations and conferences. Her extensive background in clinical research protocols, bioinformatics, and genomics positions her as a thought leader in the pharmaceutical industry, particularly in the context of infectious diseases and diabetes management. Through her leadership at GCR LLC, Dr. Beier continues to shape the future of geriatric pharmacotherapy, ensuring that advancements in pharmacogenomics translate into improved patient outcomes and quality of care for older adults.
